<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Meijers, C.</title>
    <link>http://repub.eur.nl/res/aut/1393/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Homozygous nonsense mutations in KIAA1279 are associated with malformations of the central and enteric nervous systems (Article)</title>
      <link>http://repub.eur.nl/res/pub/8492/</link>
      <pubDate>2005-01-01T00:00:00Z</pubDate>
      <description>We identified, by homozygosity mapping, a novel locus on 10q21.3-q22.1 for
      Goldberg-Shprintzen syndrome (GOSHS) in a consanguineous Moroccan family.
      Phenotypic features of GOSHS in this inbred family included microcephaly
      and mental retardation, which are both central nervous system defects, as
      well as Hirschsprung disease, an enteric nervous system defect.
      Furthermore, since bilateral generalized polymicogyria was diagnosed in
      all patients in this family, this feature might also be considered a key
      feature of the syndrome. We demonstrate that homozygous nonsense mutations
      in KIAA1279 at 10q22.1, encoding a protein with two tetratrico peptide
      repeats, underlie this syndromic form of Hirschsprung disease and
      generalized polymicrogyria, establishing the importance of KIAA1279 in
      both enteric and central nervous system development.</description>
    </item> <item>
      <title>Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility (Article)</title>
      <link>http://repub.eur.nl/res/pub/8504/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>We recently reported that a sequence variant in the cell-cycle-checkpoint
      kinase CHEK2 (CHEK2 1100delC) is a low-penetrance breast
      cancer-susceptibility allele in noncarriers of BRCA1 or BRCA2 mutations.
      To investigate whether other CHEK2 variants confer susceptibility to
      breast cancer, we screened the full CHEK2 coding sequence in
      BRCA1/2-negative breast cancer cases from 89 pedigrees with three or more
      cases of breast cancer. We identified one novel germline variant, R117G,
      in two separate families. To evaluate the possible association of R117G
      and two germline variants reported elsewhere, R145W and I157T with breast
      cancer, we screened 737 BRCA1/2-negative familial breast cancer cases from
      605 families, 459 BRCA1/2-positive cases from 335 families, and 723
      controls from the United Kingdom, the Netherlands, and North America. All
      three variants were rare in all groups, and none occurred at significantly
      elevated frequency in familial breast cancer cases compared with controls.
      These results indicate that 1100delC may be the only CHEK2 allele that
      makes an appreciable contribution to breast cancer susceptibility.</description>
    </item> <item>
      <title>Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations (Article)</title>
      <link>http://repub.eur.nl/res/pub/5956/</link>
      <pubDate>2002-05-01T00:00:00Z</pubDate>
      <description>Mutations in BRCA1 and BRCA2 confer a high risk of breast and ovarian cancer, but account for only a small fraction of breast cancer susceptibility. To find additional genes conferring susceptibility to breast cancer, we analyzed CHEK2 (also known as CHK2), which encodes a cell-cycle checkpoint kinase that is implicated in DNA repair processes involving BRCA1 and p53 (refs 3,4,5). We show that CHEK2(*)1100delC, a truncating variant that abrogates the kinase activity, has a frequency of 1.1% in healthy individuals. However, this variant is present in 5.1% of individuals with breast cancer from 718 families that do not carry mutations in BRCA1 or BRCA2 (P = 0.00000003), including 13.5% of individuals from families with male breast cancer (P = 0.00015). We estimate that the CHEK2(*)1100delC variant results in an approximately twofold increase of breast cancer risk in women and a tenfold increase of risk in men. By contrast, the variant confers no increased cancer risk in carriers of BRCA1 or BRCA2 mutations. This suggests that the biological mechanisms underlying the elevated risk of breast cancer in CHEK2 mutation carriers are already subverted in carriers of BRCA1 or BRCA2 mutations, which is consistent with participation of the encoded proteins in the same pathway.</description>
    </item> <item>
      <title>The transcription factor GATA6 is essential for branching morphogenesis and epithelial cell differentiation during fetal pulmonary development (Article)</title>
      <link>http://repub.eur.nl/res/pub/9590/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>Recent loss-of-function studies in mice show that the transcription factor GATA6 is important for visceral endoderm differentiation. It is also expressed in early bronchial epithelium and the observation that this tissue does not receive any contribution from Gata6 double mutant embryonic stem (ES) cells in chimeric mice suggests that GATA6 may play a crucial role in lung development. The aim of this study was to determine the role of GATA6 in fetal pulmonary development. We show that Gata6 mRNA is expressed predominantly in the developing pulmonary endoderm and epithelium, but at E15.5 also in the pulmonary mesenchyme. Blocking or depleting GATA6 function results in diminished branching morphogenesis both in vitro and in vivo. TTF1 expression is unaltered in chimeric lungs whereas SPC and CC10 expression are attenuated in abnormally branched areas of chimeric lungs. Chimeras generated in a ROSA26 background show that endodermal cells in these abnormally branched areas are derived from Gata6 mutant ES cells, implicating that the defect is intrinsic to the endoderm. Taken together, these data demonstrate that GATA6 is not essential for endoderm specification, but is required for normal branching morphogenesis and late epithelial cell differentiation.</description>
    </item> <item>
      <title>A consanguineous family with Hirschsprung disease, microcephaly, and mental retardation (Goldberg-Shprintzen syndrome) (Article)</title>
      <link>http://repub.eur.nl/res/pub/9394/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>Hirschsprung disease, mental retardation, microcephaly, and specific
          craniofacial dysmorphism were observed in three children from a large,
          consanguineous, Moroccan family. A fourth child showed similar clinical
          features, with the exception of Hirschsprung disease. The association of
          these abnormalities in these children represents the Goldberg-Shprintzen
          syndrome (OMIM 235730). Mutation scanning of genes potentially involved in
          Hirschsprung disease, RET, GDNF, EDN3, and EDNRB, showed a sequence
          variant, Ser305Asn, in exon 4 of the EDNRB gene in the index patient of
          this family. The Ser305Asn substitution present in two of the four
          patients and four healthy relatives and absent in one of the remaining two
          patients illustrates the difficulties in interpreting the presence of
          mutations in families with Hirschsprung disease. It is unlikely that the
          EDNRB variant contributes to the phenotype. This consanguineous family
          might be useful for the identification of a Goldberg-Shprintzen locus.</description>
    </item> <item>
      <title>Constipation as the presenting symptom in de novo multiple endocrine neoplasia type 2B (Article)</title>
      <link>http://repub.eur.nl/res/pub/8889/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>The murine homologue of HIRA, a DiGeorge syndrome candidate gene, is expressed in embryonic structures affected in human CATCH22 patients (Article)</title>
      <link>http://repub.eur.nl/res/pub/8655/</link>
      <pubDate>1997-01-01T00:00:00Z</pubDate>
      <description>A wide spectrum of birth defects is caused by deletions of the DiGeorge
          syndrome chromosomal region at 22q11. Characteristic features include
          cranio-facial, cardiac and thymic malformations, which are thought to
          arise form disturbances in the interactions between hindbrain neural crest
          cells and the endoderm of the pharyngeal pouches. Several genes have been
          identified in the shortest region of deletion overlap at 22q11, but
          nothing is known about the expression of these genes in mammalian embryos.
          We report here the isolation of several murine embryonic cDNAs of the
          DiGeorge syndrome candidate gene HIRA. We identified several alternatively
          spliced transcripts. Sequence analysis reveals that Hira bears homology to
          the p60 subunit of the human Chromatin Assembly Factor I and yeast hir1p
          and Hir2p, suggesting that Hira might have some role in chromatin assembly
          and/or histone regulation. Whole mount in situ hybridization of mouse
          embryos at various stages of development show that Hira is ubiquitously
          expressed. However, higher levels of transcripts are detected in the
          cranial neural folds, frontonasal mass, first two pharyngeal arches,
          circumpharyngeal neural crest and the limb buds. Since many of the
          structures affected in DiGeorge syndrome derive from these Hira expressing
          cell populations we propose that haploinsufficiency of HIRA contributes to
          at least some of the features of the DiGeorge phenotype.</description>
    </item>
  </channel>
</rss>